Rangers Pharmaceutical A/S: Financial statements 2022
CVR: 40381015
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Rangers Pharmaceutical A/S (CVR 40381015) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,123,696 and a net result of DKK -53,111,223 compared with DKK -2,726,374 the year before. Equity in the 2022 report amounted to DKK -53,644,195.
- Gross Profit
- DKK -1,123,696
- Profit/Loss
- DKK -53,111,223
- Equity
- DKK -53,644,195
- Total Assets
- DKK 554,616
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1.1M | -53.1M | -53.6M | - |
| 2021 | - | -2.7M | -2.7M | -533K | 0 |
| 2020 | - | -302K | -4.1M | -829K | 1 |
Official annual report
Keep an eye on Rangers Pharmaceutical A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Rangers Pharmaceutical A/S has published its annual report for 2021. Gross profit came to DKK -2,731,822, and the net result was DKK -2,726,374.
As of March 24, 2022, Farhan Lalani has joined the board of directors of Rangers Pharmaceutical A/S.
As of March 24, 2022, Clifford Starke is registered as adm. dir. of Rangers Pharmaceutical A/S.
As of March 24, 2022, Farhan Lalani has stepped down as director of Rangers Pharmaceutical A/S.
As of March 23, 2022, Farhan Lalani has left the board of directors of Rangers Pharmaceutical A/S.
About Rangers Pharmaceutical A/S
Rangers Pharmaceutical A/S is a Danish company of the type Aktieselskab based in København K, founded in 2019. The company is in liquidation. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Niels Løber. The company is owned by Klokken Aarhus Inc.. The company has 1 employee (2019). In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092.
